Physician profile
Anna D Hohler
NPI 1689646606
$6,377.13
in general payments reported to CMS, 2019-2025
12 companies · $3,726 in 2025
The $3,726 reported for 2025 was more than what 82% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,228 · 2020: $280 · 2021: $327 · 2022: $339 · 2023: $292 · 2024: $185 · 2025: $3,726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,515 · Food and Beverage: $1,688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,515.17 |
| Food and Beverage | $1,687.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,192.02 | 2021-2025 | Vercise, General - Dbs |
| Medtronic USA, INC. | $1,232.84 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $438.52 | 2019-2023 | Nuplazid |
| Amneal Pharmaceuticals LLC | $427.13 | 2022-2025 | Ongentys, Crexont, Rytary |
| Abbvie INC. | $352.86 | 2021-2025 | |
| Medtronic, INC. | $318.68 | 2022-2025 | Percept PC Brainsense |
| Mdd US Operations, LLC | $115.71 | 2025 | |
| Pfizer INC. | $114.77 | 2024-2025 | |
| Jazz Pharmaceuticals INC. | $113.75 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $30.36 | 2022 | |
| Siemens Medical Solutions USA, INC. | $24.17 | 2023 | Artis Icono Biplane |
| Allergan, INC. | $16.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Hohler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.